Covered recipient · General Payments record
LORISSA J LORENZO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,891.14
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $679.78 | 34 |
| Education | $107.45 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $368.68 | 20 |
| Janssen Biotech, Inc. | $180.30 | 6 |
| E.R. Squibb & Sons, L.L.C. | $78.75 | 3 |
| Lilly USA, LLC | $56.42 | 3 |
| Regeneron Healthcare Solutions, Inc. | $32.12 | 1 |
| GENZYME CORPORATION | $28.30 | 1 |
| Amgen Inc. | $27.55 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.48 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556520 | CMS |
| ABBVIE INC. | $8.45 | 02/22/2024 | Education | Undisputed | 01/23/2026 | 1107556522 | CMS |
| ABBVIE INC. | $12.00 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556524 | CMS |
| ABBVIE INC. | $88.49 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556526 | CMS |
| ABBVIE INC. | $9.48 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556528 | CMS |
| ABBVIE INC. | $6.56 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556530 | CMS |
| ABBVIE INC. | $10.01 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556532 | CMS |
| ABBVIE INC. | $4.08 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556534 | CMS |
| ABBVIE INC. | $26.39 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556536 | CMS |
| ABBVIE INC. | $13.87 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556538 | CMS |
| ABBVIE INC. | $26.55 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556540 | CMS |
| ABBVIE INC. | $27.66 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556542 | CMS |
| ABBVIE INC. | $12.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556544 | CMS |
| ABBVIE INC. | $27.20 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556546 | CMS |
| ABBVIE INC. | $7.90 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556548 | CMS |
| ABBVIE INC. | $23.90 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556550 | CMS |
| ABBVIE INC. | $17.70 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556552 | CMS |
| ABBVIE INC. | $7.19 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556554 | CMS |
| ABBVIE INC. | $5.16 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556556 | CMS |
| ABBVIE INC. | $15.29 | 12/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107556558 | CMS |
| Amgen Inc. | $27.55 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117614129 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.97 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101751138 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.17 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101751141 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101751178 | CMS |
| GENZYME CORPORATION | $28.30 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139792405 | CMS |
| Janssen Biotech, Inc. | $16.00 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078286759 | CMS |
| Janssen Biotech, Inc. | $14.03 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078286741 | CMS |
| Janssen Biotech, Inc. | $15.29 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078286761 | CMS |
| Janssen Biotech, Inc. | $10.98 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078286747 | CMS |
| Janssen Biotech, Inc. | $99.00 | 10/30/2024 | Education | Undisputed | 01/23/2026 | 1078286749 | CMS |
| Janssen Biotech, Inc. | $25.00 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078286757 | CMS |
| Lilly USA, LLC | $17.89 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135796990 | CMS |
| Lilly USA, LLC | $20.76 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135804130 | CMS |
| Lilly USA, LLC | $17.77 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135804968 | CMS |
| Novartis Pharmaceuticals Corporation | $15.11 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087005828 | CMS |
| Regeneron Healthcare Solutions, Inc. | $32.12 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114334401 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.